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ABSTRACT 
The  purpose  of  this  study  was  to  formulate  diclofenac  sodium  floating  matrix  drug  delivery  system  by  melt  granulation  technique.  These  tablets  were 
developed to prolong gastric residence time and increase its bio availability. The diclofenac sodium tablets of 100mg were developed by using different bees 
wax combinations  which are  prepared by  melt granulation technique  by  using  polymers  such as  Hydroxy  propyl  methyl cellulose(HPMC  K15M), ethyl 
cellulose, bees wax alone or in combination with cetyl alcohol, sodium bicarbonate as a gas generating agent and other standard excipients. The prepared 
granules are subjected to pre compression studies such as angle of repose, bulk density, tapped density, compressibility index, Hausner’s ratio. The optimized 
formulation produced monolithic tablets with optimum hardness, uniform thickness, consistent weight uniformity and low friability. The results of dissolution 
studies, floating lag time indicates that formulations F6 exhibited good and controlled drug release .  
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INTRODUCTION 
Floating drug delivery systems were first described by Davis 
in  1968.These  systems  were  used  to  prolong  the  gastric 
residence  time  of  drug  delivery  systems.  They  remain 
buoyant in the stomach for prolonged period of time without 
affecting  the  gastric  emptying  rate  of  other  contents.  A 
floating dosage form is useful for those drugs that act locally 
in the proximal gastro intestinal tract are unstable in lower 
parts of gut or are poorly absorbed in the intestine
1-3. 
Diclofenac sodium is a nonsteroidal anti infalammatory drugs 
having  chemical  name  sodium  2-[(2,6-dichlorophenyl)-
amino] Phenyl acetate. The most frequent adverse side effects 
occurring  with  diclofenac  sodium  are  gastro  intestinal 
disturbances, peptic ulceration and gastro intestinal bleeding, 
hence  there  is  potential  need  for  a  floating  matrix  dosage 
form for this drug to minimize gastric erosion side effect. It’s 
biological half life on the other hand is very short, sustaining 
its  anti  inflammatory  activity  only  for  a  few  hours  and 
associated adverse effects; it is considered as an ideal model 
drug  for floating matrix drug delivery
4-10. The present study 
is to formulate rate controlled floating drug delivery system 
of  diclofenac  sodium  which  is  primarily  absorbed  from 
stomach,  so  by  increasing  the  GRT  of  the  drug  ,  the  bio 
availability  can  be  increased.  As  the  moderately  weekly 
acidic drug, so the stomach is the major absorption site for 
the drug. So basing on this fact the drug is made to float in 
the  stomach  using  mechanism  of  buoyancy  by  using  gas 
generating agent and the drug is delivered in the sustained 
release dosage form by using HPMC as swell able polymer to 
formation of gel layer for controlled release. Ethyl cellulose 
is  used  to  retard  the  disintegration  and  also  dissolution. 
Microcrystalline  cellulose  is  used  as  diluents
11.  The  study 
also includes various evaluation studies of diclofenac sodium 
tablet and the effect of processing variables on it. A possible 
interaction between drug and polmers are also investigated by 
FTIR study.  
The objective of this study is to formulate diclofenac sodium  
floating  matrix  tablets    using  hydrophobic  wax  materials, 
sodium bicarbonate as gas generating agent and to evaluate 
the in vitro release characteristics and to predict and correlate 
the release behavior of diclofenac from the matrix 
 
MATERIALS AND METHODS 
Materials 
Diclofenac  sodium  as  a  gift  of  hetero  chemicals  Ltd, 
Hyderabad, HPMC  K15M by SD  fine chemicals, Mumbai, 
Ethyl cellulose from Loba chemicals Pvt Ltd, Mumbai, Micro 
crystalline  cellulose  and  talc  from  Yarrow  chemicals  Ltd, 
Mumbai.  Sodium  bicarbonate,  Magnesium  stearate  for 
Thomas bakers Ltd, Mumbai  
 
Methods 
Preparation of standard curve of diclofenac sodium 
Solutions  ranging  fron  2  to  10  microgram  per  ml  were 
prepared  by  using  ethanol  and  0.1N  HCl  absorbance  was 
measured for each solution at lambda max of 276nm, using 
Shimadzu  spectrophotometer.  Correlation  coefficient  was 
found to be 0.9996 in 0.1N HCl. 
 
Preparation  of  floating  tablets  by  melt  granulation 
technique 
Floating  tablets,  each  containing  100mg  diclofenac  were 
formulated  by  a  conventional  melt  technique.  The 
composition of various formulations of the tablets with their 
codes  is  listed  in  table.  The  composition  with  respect  to 
polymer  combination  was  selected  on  the  basis  of  trial 
preparation  of  tablets.  The  amount  of  bees  wax  was 
decreased gradually and the reduced amount of bees wax was 
replaced by cetyl alcohol. As per each formulation batch code 
required quantity of bees wax and cetyl alcohol were weighed 
and melted separately in a large china dish over a water bath. 
The  drug  was  added  to  molten  wax  and  mixed  well. 
Previously  weighed  quantities  of  ethyl  cellulose,  HPMC, 
Micro crystalline cellulose and sodium carbonate were added 
to  the  drug  wax  mixture  and  mixed  well.  After  through 
mixing china dish was removed from water bath and cooled. 
The coherent mass was then scrapped from the china dish and 
was passed through sieve no 30.The amount of ingredients 
that are added for each tablet is given in following table 1. Subramaniyan Chandra et al. Int. Res. J. Pharm. 2013, 4 (5) 
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Evaluation of granules 
Angle of repose 
Flowability of different batch of granules was determined by 
calculating angle of repose by fixed height method. A funnel 
with 10mm inner diameter of stem was fixed at a height of 2 
cm over the platform. About 10 gm  of sample was slowly 
passed  along  the  wall  of  the  funnel  till  the  tip  of  the  pile 
formed and touches the stem of the funnel. A rough circle 
was drawn around the pile base and the radius of the powder 
cone was measured.  
Angle of repose was calculated from the average radius using 
the following formula. 
 
Ө = tan
-1(h/r) 
 
Where,Ө = Angle of repose, h= height of the pile,  
r== average radius of the powder cone  
 
Bulk density 
Apparent bulk density was determined by pouring preserved 
drug excipient blend in to graduated cylinder and measuring 
the volume and weight “as it is”. It is expressed in g/ml and is 
given by    
Db = M / Vo 
 
Where, M is the mass of powder and Vo is the bulk volume of 
the powder 
 
Tapped density 
It was determined by placing a graduated cylinder, containing 
a  known  mass  of  drug  excipients  blend,  on  mechanical 
tapping  apparatus.    the  tapped  volume  was  measured  by 
tapping  the  powder  to  constant  volume.  It  is  expressed  in 
g/ml and is given by  
Dt = M/Vt 
 
Where M is the mass of powder and Vt  is the tapped  volume 
of the powder 
 
Powder flow properties 
The flow properties were determined by 
 
Carr’s index(i) 
It is expressed in percentage and is expressed by   
 
I = Dt - Db / Dt 
 
Where Dt  is the tapped density of the powder and  Db  bulk 
density of the powder 
 
Hausner’s ratio  
It is expressed in percentage and is expressed by  
 
H = Dt/ Db 
 
Where  Dt is the tapped density of the powder and Db  is the 
bulk density of the powder 
 
Compression of tablets 
After evaluation of granules were then compressed in to the 
tablet  by  direct  compression  technique  using  10  punches 
tablet punching machine 
 
 
Evaluation of tablets  
Weight variation 
20 tablets were selected at random and average weights were 
determined.  The  individual  tablets  weighed  the  individual 
weight was compared with the average. 
 
Thickness and diameter 
The thickness and diameter of the tablets was measured by 
Vernier calipers. It is expressed in mm. 
 
Hardness 
The hardness of the tablet was determined using a Monsanto 
hardness tester. It is expressed in kg/cm
2. 
 
Friability (f)  
The  friability  of  the  tablet  was  determined  using  roche 
friabilator. The friabilator was operated at 25 Rpm per min 
for  4  min  (100  revolutions).  The  tablets  were  weighed 
again(Wfinal).The % friability was then calculated by  
 
F = W initial  - Wfinal / Winitial * 100 
 
Content uniformity 
20  tablets  were  taken  and  amount  of  drug  present  in  each 
tablet was determined. The tablets were crushed in a mortar 
and the powder equivalent 100mg of drug was transferred to 
100ml standard flask. The powder was dissolved in 5ml of 
methanol and make up to volume with 0.1N HCl. The sample 
was mixed thoroughly and filtered through 0.45µ membrane 
filter. The filtered solution was diluted suitably and analyzed 
for drug content by UV spectrophotometer at lambda max of 
276nm using 0.1N HCL as blank. 
 
In vitro buoyancy studies 
The  randomly  selected  tablets  from  each  formulation  were 
kept in a 100ml beaker containing simulated gastric fluid pH 
1.2 as per USP. The time taken for the tablet to rise to the 
surface  and  float  was  taken  as  a  floating  lag  time.  the 
duration of time the dosage form constantly remained on the 
surface of medium was determined as the total floating time. 
 
In vitro dissolution studies 
The  dissolution  test  was  performed  using  900ml  of  0.1N 
HCL at 37 ±0.5
oc and 75 rpm. A sample (5ml) of the solution 
was  withdrawn  from  the  dissolution  apparatus  hourly  and 
samples were replaced with fresh dissolution medium.  The 
samples were filtered through a 0.45 microns membrane filter 
and  diluted  to  a  suitable  concentration  with  0.1N  HCL. 
Absorbance of these solutions were measured at 276nm using 
a Shimadzu UV spectrophotometer. 
   
RESULTS AND DISCUSSION 
Diclofenac sodium is a water insoluble drug. Its poor inherent 
compressibility coupled with associated side effect possess a 
significant  challenge  for  developing  floating  tablets.  For 
developing  floating  tablets  with  desirable  drug  release 
profile, cost effectiveness and broader regulatory acceptance 
combination of  HPMC, Ethyl cellulose, Bees wax and Cetyl 
alcohol was chosen as release controlling polymers, sodium 
bicarbonate was added as a gas generating agent. 
The formulated granule blends of different formulations (F1 
to F10) were evaluated for angle of repose, tapped density, 
bulk density, Carr’s index and Hausner’s ratio.  
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TABLE 1: FORMUALTION INGREDIENTS FOR FLOATING MATRIX TABLETS OF DICLOFENAC SODIUM 
 
Ingredients  F1  F2  F3  F4  F5  F6  F7  F8  F9  F10 
Diclofenac sodium  100  100  100  100  100  100  100  100  100  100 
Bees wax  90  90  90  90  90  70  60  50  40  35 
Cetyl alcohol  -  -  -  -  -  20  30  40  50  55 
HPMC K15M  64  64  64  64  64  64  64  64  64  64 
Ethyl cellulose  30  30  30  30  30  30  30  30  30  30 
Microcrystallinecellulose  60  50  40  35  30  30  30  30  30  30 
Sodium bicarbonate  -  10  20  25  30  30  30  30  30  30 
Magnesium stearate  3  3  3  3  3  3  3  3  3  3 
talc  3  3  3  3  3  3  3  3  3  3 
Total weight of tablet in mg  350  350  350  350  350  350  350  350  350  350 
 
TABLE 2:  PRE COMPRESSION PARAMETERS OF FORMULATED GRANULES 
 
Formulation code  Angle of repose in degree  Bulk density  Tapped density  Carr’s index  Hausner’s ratio 
F1  15.2  0.57  0.71  19.0  1.24 
F2  12.4  0.55  0.67  16.9  1.22 
F3  10.2  0.55  0.70  19.9  1.27 
F4  14.0  0.54  0.73  21.5  1.35 
F5  17.7  0.53  0.67  20.8  1.26 
F6  16.6  0.57  0.74  23.1  1.29 
F7  19.2  0.56  0.74  23.7  1.30 
F8  18.7  0.57  0.73  22.8  1.32 
F9  20.8  0.58  0.72  18.7  1.24 
F10  20.3  0.55  0.71  18.9  1.24 
 
TABLE 3: POST COMPRESSION PROPERTIES OF FORMULATED FLOATING TABLETS 
 
Formulation code  %of weight 
variation 
Thickness 
(mm) 
Diameter  hardness  Friability  Drug 
content 
% Drug 
release 
F1  350±4  5.3±0.01  9.9±0.01  4.0±0.01  0.28±0.01  96.6  69.02 
F2  350±5  5.5±0.01  9.9±0.01  4.9±0.01  0.22±0.01  96.1  70.20 
F3  350±4  5.3±0.01  9.9±0.01  4.9±0.01  0.18±0.01  97.0  71.13 
F4  350±3  5.3±0.01  9.9±0.01  4.9±0.01  0.44±0.01  96.1  72.23 
F5  350±2  5.4±0.01  9.9±0.02  4.4±0.01  0.38±0.01  96.1  72.21 
F6  350±4  5.2±0.01  9.9±0.01  5.0±0.01  0.49±0.01  95.6  75.02 
F7  350±3  5.5±0.01  9.9±0.02  5.0±0.01  0.41±0.01  97.0  59.85 
F8  350±4  5.3±0.01  9.9±0.01  5.0±0.01  0.28±0.01  96.6  58.52 
F9  350±3  5.4±0.01  9.9±0.02  5.0±0.01  0.25±0.01  95.6  58.07 
F10  350±4  5.3±0.01  9.9±0.01  5.0±0.01  0.28±0.01  96.6  57.96 
 
 
TABLE 4: IN VITRO BUOYANCY STUDIES RESULTS OF DICLOFENAC SODIUM FLOATING MATRIX TABLETS 
 
Formulation code  Amount of sodium bicarbonate in mg  Buoyancy lag time in min  Total floating time in hrs 
F1  0  Did not float  did not float 
F2  10  30  >4 
F3  20  18  >6 
F4  25  10  >8 
F5  30  5  >12 
F6  30  5  >12 
F7  30  5  >12 
F8  30  5  >12 
F9  30  4  >12 
F10  30  4  > 12 
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Figure 1 
 
 
 
Figure 2 
 
The  results  of  angle  of  repose  (<25)  indicated  good  flow 
properties  of  the  entire  granule  blend.  The  compressibility 
index  value  were  recorded,  result  in  good  excellent  flow 
properties. 
Formulated  powder  blends    density;  Porosity  and  hardness 
are  often interrelated  properties  and are likely to influence 
compressibility, porosity, dissolution profile and properties of 
tablets  made  from    it.  The  results  of  percentage  porosity 
indicating  that  packaging  of  the  granule  blend  may  range 
from close to lose packaging and also confirming that particle 
are not of greatly different sizes. All the  results  indicate that 
the    formulated  granule  blend  possessing  satisfactory  flow 
properties and compressibility. 
The  tablets  of  different  formulations  (F1  to  F10)  were 
evaluated for various parameters they are thickness, diameter, 
hardness,  friability,  percentage  weight  variation  percentage 
drug  content  and  dissolution  studies.  All  the  formulations 
showed uniform thickness and diameter. In a weight variation 
test, the pharmacopeias limit for the percentage deviation for 
the  tablets  of  more  than  350  mg  is  ±  5%.  The  average 
percentage deviation of all tablet formulations was found  to 
be within the above limit and hence all formulations passed 
the test for uniformity of weight as per official requirements. 
Drug  content  was  found  to  be  uniform  among  different 
batches of the tablets and the percentage of the drug content 
was more than 96%. The hardness of all the formulation was 
between 4.0 to 5.5 kg/cm
2. The Percentage friability for all 
formulations was  below 1% indicating that the friability is 
within the prescribed limits. The percentage drug release is 
found  to  be  75.02%.    All  the  tablet  formulations  showed 
pharmacotechnical  properties  and  complied  with 
specifications  for  weight  variation,  drug  content,  hardness 
and friability shown in the table 2 & 3. 
 
In vitro buoyancy studies 
The  floating  behavior  studies  it  was  found  that  as  the 
concentration  of  effervescent  mixture  increase,  the  floating 
lag time, floating duration and matrix integrity decreased and 
vice versa were observed through results. A reverse trend was 
observed on increasing the polymer concentration. The Initial 
batch is prepared without sodium bicarbonate did not show 
any sign of floating. Therefore, sodium bicarbonate was used 
as  a  gas  generating  agent  in  order  to  float  the  tablet.  The 
sodium bicarbonate induces Co2 generation in the presence 
of  dissolution  medium  (0.1N  HCl).  The  gas  generated  is 
trapped and protected within the gel formed by hydration of 
the polymer, thus decreasing the density of the tablet below 
1gm/ml, and the tablet become buoyant. To study the effect 
of  sodium  bicarbonate  concentration  on  floating  lag  tie 
batches  F1  to  F10  were  selected.  It  was  found  that  as  the 
amount of sodium bicarbonate increases the floating lag time 
decreases. Thus sodium bicarbonate 30 mg was essential to 
achieve optimum in vitro buoyancy (i.e floating lag time of 4-
5 minutes and floating duration of 12 hrs). Further  increase 
in the concentration of sodium carbonate does not show any 
significant effect of floating behavior. The increased amount 
of  sodium  bicarbonate  caused  a  large  amount  of 
effervescence,  which  in  turn  resulted  in  pore  formation, 
which led to rapid drug release. Thus 30mg concentration of 
sodium bicarbonate was kept constant for batches F5 to F10, 
which showed floating lag time between 4 and 5 minutes and 
remained floating for more than 12 hours. The relationship 
between the amounts of gas generating agents and floating 
lag time as well as the duration of floating are shown in table. 
It was observed that floating lag time for this system in the 
range of 4 to 15 min and flotation was achieved maximum at 
gas generating quantity of 30 mg with in 4 min. Therefore the 
formulation F5 to F10 was selected for In-vitro Dissolution 
study of floating matrix tablet. as shown in the table 4. 
 
In vitro dissolution studies 
Depending  on  floating  lag  time  and  total  floating  time 
formulation F5 to F10were selected for in vitro dissolution 
study.  In  formulations  F5  to  F10  were  showed  72.21%, 
75.02%, 59.85%, 58.52%, 58.07% and 57.96% at the end 12
th 
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formulation F7, F8, F9 and F10 was found to be less drug 
release  characteristics  due  to  excess  of  cetyl  alcohol  in 
comparison  F5  and  F6.  The  drug  released  from  the 
formulations diffusion coupled with erosion. Formulation F6 
is  selected  as  optimized  formulation  among  all  the 
formulations showing 75 % sustained release at the end of 12 
hours as shown in following figures 1&2. 
 
Compatibility studies of infra red 
IR  spectra  of  drug  diclofenac  sodium  and  optimized 
formulation F5 (drug and Polymer mixture) were shown in 
tables  and  figures.  The  studies  revealed  that  there  was  no 
significant interaction between drug and polymer. 
 
CONCLUSION 
The  present  study  was  to  develop  an  floating  system  of 
diclofenac sodium with the use of wax materials, swell able 
polymer, release retardant and alkalizing agent which proved 
to  be  an  ideal  formulation,  as  it  released  the  drug  in  a 
controlled manner for extended period of time by maintaining 
the buoyancy. The optimized formulation F5 reveals that in 
terms of floating lag time (5minurtes) and floating duration of 
12 hours and drug release more than 75 % at the end of 12 
hrs.  This  results  in  developing,  because  a  longer  gastric 
residence  time  is  an  important  condition  for  higher 
bioavailability of the drugs included in floating matrix dosage 
forms. 
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